|
Chinook Therapeutics
|
8.4 |
$21M |
|
818k |
26.20 |
|
Madrigal Pharmaceuticals
(MDGL)
|
8.0 |
$20M |
|
70k |
290.25 |
|
Bristol Myers Squibb Put Option
(BMY)
|
4.9 |
$13M |
|
175k |
71.95 |
|
Establishment Labs Holdings Ord
(ESTA)
|
4.9 |
$13M |
|
191k |
65.65 |
|
Verona Pharma Sponsored Adr
(VRNA)
|
4.3 |
$11M |
|
418k |
26.13 |
|
Ascendis Pharma A S Sponsored Adr
(ASND)
|
3.4 |
$8.7M |
|
71k |
122.13 |
|
BioMarin Pharmaceutical
(BMRN)
|
3.2 |
$8.3M |
|
80k |
103.49 |
|
Prometheus Biosciences
|
3.2 |
$8.3M |
|
75k |
110.00 |
|
Ventyx Biosciences
(VTYX)
|
3.1 |
$7.9M |
|
241k |
32.79 |
|
Morphic Hldg
(MORF)
|
2.9 |
$7.5M |
|
281k |
26.75 |
|
Arcellx Common Stock
(ACLX)
|
2.9 |
$7.4M |
|
240k |
30.98 |
|
Cymabay Therapeutics
|
2.8 |
$7.2M |
|
1.1M |
6.27 |
|
Astria Therapeutics
(ATXS)
|
2.8 |
$7.0M |
|
473k |
14.89 |
|
Cerevel Therapeutics Hldng I
(CERE)
|
2.7 |
$6.8M |
|
215k |
31.54 |
|
Inari Medical Ord
|
2.2 |
$5.7M |
|
90k |
63.56 |
|
Viking Therapeutics
(VKTX)
|
2.2 |
$5.6M |
|
600k |
9.40 |
|
Moderna Put Option
(MRNA)
|
2.1 |
$5.4M |
|
30k |
179.62 |
|
Amgen Put Option
(AMGN)
|
2.1 |
$5.3M |
|
20k |
262.64 |
|
Horizon Therapeutics Pub L SHS
|
2.0 |
$5.1M |
|
45k |
113.80 |
|
Rocket Pharmaceuticals
(RCKT)
|
2.0 |
$5.1M |
|
258k |
19.57 |
|
Celldex Therapeutics Com New
(CLDX)
|
1.9 |
$4.9M |
|
110k |
44.57 |
|
Bellus Health Com New
|
1.8 |
$4.7M |
|
574k |
8.22 |
|
Geron Corporation Put Option
(GERN)
|
1.8 |
$4.6M |
|
1.9M |
2.42 |
|
Astrazeneca Sponsored Adr
(AZN)
|
1.6 |
$4.1M |
|
60k |
67.80 |
|
Cytokinetics Com New
(CYTK)
|
1.6 |
$4.0M |
|
88k |
45.82 |
|
Bridgebio Pharma Note 2.250% 2/0 (Principal)
|
1.5 |
$3.9M |
|
10M |
0.39 |
|
Bridgebio Pharma Note 2.500% 3/1 (Principal)
|
1.3 |
$3.4M |
|
7.5M |
0.45 |
|
Kura Oncology
(KURA)
|
1.3 |
$3.3M |
|
269k |
12.41 |
|
Lantheus Holdings Inc Common Stock Usd 0.01
(LNTH)
|
1.2 |
$3.1M |
|
61k |
50.96 |
|
Vaxcyte
(PCVX)
|
1.1 |
$2.9M |
|
60k |
47.95 |
|
Syndax Pharmaceuticals
(SNDX)
|
1.0 |
$2.5M |
|
100k |
25.45 |
|
Iovance Biotherapeutics
(IOVA)
|
0.9 |
$2.4M |
|
375k |
6.39 |
|
Karyopharm Therapeutics
|
0.9 |
$2.2M |
|
661k |
3.40 |
|
Cogent Biosciences
(COGT)
|
0.9 |
$2.2M |
|
193k |
11.56 |
|
Point Biopharma Global
|
0.9 |
$2.2M |
|
303k |
7.29 |
|
Novavax Com New Put Option
(NVAX)
|
0.8 |
$2.1M |
|
200k |
10.28 |
|
Xenon Pharmaceuticals
(XENE)
|
0.8 |
$2.0M |
|
50k |
39.43 |
|
Argenx Se Sponsored Adr
(ARGX)
|
0.7 |
$1.9M |
|
5.0k |
378.83 |
|
Novocure Ord Shs Call Option
(NVCR)
|
0.7 |
$1.8M |
|
25k |
73.35 |
|
Alpine Immune Sciences
|
0.7 |
$1.8M |
|
248k |
7.35 |
|
Vincerx Pharma Com New
|
0.6 |
$1.5M |
|
1.5M |
1.02 |
|
Precigen Note 3.500% 7/0 (Principal)
|
0.6 |
$1.5M |
|
1.5M |
0.99 |
|
Centessa Pharmaceuticals Sponsored Ads
(CNTA)
|
0.6 |
$1.4M |
|
460k |
3.10 |
|
Esperion Therapeutics Inc Ne Note 4.000%11/1 (Principal)
|
0.5 |
$1.4M |
|
2.5M |
0.55 |
|
Kalvista Pharmaceuticals
(KALV)
|
0.5 |
$1.3M |
|
188k |
6.76 |
|
Bioatla
(BCAB)
|
0.5 |
$1.2M |
|
150k |
8.25 |
|
Dyne Therapeutics
(DYN)
|
0.4 |
$1.1M |
|
92k |
11.59 |
|
Lianbio Sponsored Ads
(LIANY)
|
0.4 |
$1.1M |
|
650k |
1.64 |
|
Nurix Therapeutics
(NRIX)
|
0.3 |
$878k |
|
80k |
10.98 |
|
Mirum Pharmaceuticals
(MIRM)
|
0.3 |
$780k |
|
40k |
19.50 |
|
Foghorn Therapeutics
(FHTX)
|
0.3 |
$702k |
|
110k |
6.38 |
|
Seagen
|
0.3 |
$643k |
|
5.0k |
128.51 |
|
Context Therapeutics
(CNTX)
|
0.2 |
$584k |
|
884k |
0.66 |
|
Inozyme Pharma
(INZY)
|
0.2 |
$525k |
|
500k |
1.05 |
|
Nuvation Bio Com Cl A
(NUVB)
|
0.2 |
$480k |
|
250k |
1.92 |
|
Immatics *w Exp 07/01/202
(IMTXW)
|
0.2 |
$470k |
|
187k |
2.51 |
|
Milestone Pharmaceuticals
(MIST)
|
0.2 |
$396k |
|
100k |
3.96 |
|
Scilex Holding *w Exp 11/10/202
(SCLXW)
|
0.0 |
$3.4k |
|
18k |
0.19 |
|
Medicus Sciences Acquisition *w Exp 02/12/202
|
0.0 |
$2.9k |
|
33k |
0.09 |
|
Scilex Holding
|
0.0 |
$1.8k |
|
463.00 |
3.99 |